JOHN A MOORE Insider Trading $ELTP ELITE PHARMACEUTICALS INC /NV/
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOHN A MOORE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOHN A MOORE. JOHN A MOORE is Chairman of the Board in SCIENTIFIC INDUSTRIES INC ($SCND) and Director in SCIENTIFIC INDUSTRIES INC ($SCND) and Director in ACORN ENERGY, INC. ($ACFN) and Director in ELITE PHARMACEUTICALS INC /NV/ ($ELTP).
JOHN A MOORE in ELITE PHARMACEUTICALS INC /NV/
Trading Symbol: ELTPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JOHN A MOORE: Director
Holdings: 53,000 shares
Current Value: $7,950
Latest Transaction: Jan 25 2005
$ELTP Market Capitalization: $138.57M
$ELTP Previous Close: $0.15
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JOHN A MOORE in ELITE PHARMACEUTICALS INC /NV/
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACFN, ELTP, SCND
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 25 2005 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Sell | S | 4.22 | 5,000 | 21,100 | 53,000 | 58 K to 53 K (-8.62 %) |
Jan 25 2005 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Sell | S | 4.23 | 10,000 | 42,300 | 53,000 | 63 K to 53 K (-15.87 %) |
Jan 25 2005 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Sell | S | 4.21 | 10,000 | 42,116 | 53,000 | 63 K to 53 K (-15.87 %) |
Jan 25 2005 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Sell | S | 4.21 | 10,000 | 42,145 | 53,000 | 63 K to 53 K (-15.87 %) |
Jan 25 2005 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Sell | S | 4.26 | 25,000 | 106,470 | 53,000 | 78 K to 53 K (-32.05 %) |
Jan 25 2005 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Sell | S | 4.25 | 40,000 | 170,000 | 53,000 | 93 K to 53 K (-43.01 %) |
Jan 25 2005 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Sell | S | 4.27 | 25,000 | 106,750 | 53,000 | 78 K to 53 K (-32.05 %) |
Jan 25 2005 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Sell | S | 4.30 | 125,000 | 537,500 | 53,000 | 178 K to 53 K (-70.22 %) |
Jan 25 2005 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Sell | S | 4.32 | 50,000 | 216,000 | 53,000 | 103 K to 53 K (-48.54 %) |
Jan 25 2005 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Sell | S | 4.35 | 32,109 | 139,674 | 53,000 | 85.1 K to 53 K (-37.73 %) |
Jan 25 2005 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Sell | S | 4.31 | 25,000 | 107,633 | 53,000 | 78 K to 53 K (-32.05 %) |
Jan 25 2005 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Sell | S | 4.27 | 25,000 | 106,743 | 53,000 | 78 K to 53 K (-32.05 %) |
Jan 25 2005 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Sell | S | 4.14 | 10,000 | 41,400 | 53,000 | 63 K to 53 K (-15.87 %) |
Oct 14 2004 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Buy | P | 1.24 | 19,900 | 24,624 | 445,109 | 425.2 K to 445.1 K (+4.68 %) |
Oct 05 2004 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Buy | P | 1.20 | 7,000 | 8,400 | 425,209 | 418.2 K to 425.2 K (+1.67 %) |
Oct 05 2004 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Buy | P | 1.19 | 1,000 | 1,190 | 425,209 | 424.2 K to 425.2 K (+0.24 %) |
Oct 05 2004 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Buy | P | 1.15 | 100 | 115 | 425,209 | 425.1 K to 425.2 K (+0.02 %) |
Dec 05 2003 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Buy | P | 2.00 | 50,000 | 100,000 | 914,218 | 864.2 K to 914.2 K (+5.79 %) |
Dec 05 2003 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Buy | P | 2.00 | 50,000 | 100,000 | 914,218 | 864.2 K to 914.2 K (+5.79 %) |
Dec 05 2003 | ELTP | ELITE PHARMACEUTIC ... | MOORE JOHN A | Director | Buy | P | 2.00 | 50,000 | 100,000 | 914,218 | 864.2 K to 914.2 K (+5.79 %) |
Page: 1